Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Craig Speziali"'
Publikováno v:
Current Hematologic Malignancy Reports. 11:175-184
The majority of adults with acute lymphoblastic leukemia will achieve a first complete remission (CR). However relapse is the most common cause of treatment failure. Outcomes after relapse remain poor, with long-term survival in the order of 10 %. Tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515c6558a6191fc3e134d5d9bf31a707
https://doi.org/10.1007/s11899-016-0317-2
https://doi.org/10.1007/s11899-016-0317-2
Autor:
Mohamed Abuhaleeqa, Kristjan Paulson, Andrew Daly, Janet Nitta, Matthew D. Seftel, Yasser Abou Mourad, Craig Speziali
Publikováno v:
Leukemialymphoma. 60(3)
The optimal conditioning regimen for adults undergoing transplantation for acute lymphoblastic leukemia (ALL) remains undetermined. Cyclophosphamide and total body irradiation (Cy/TBI) has emerged as a standard myeloablative regimen but is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef6cab0f5f378be994f9daa3fe9bca8d
https://pubmed.ncbi.nlm.nih.gov/30160568
https://pubmed.ncbi.nlm.nih.gov/30160568
Autor:
Andrew Daly, Matthew D. Seftel, Kristjan Paulson, Janet Nitta, Yasser Abou Mourad, Craig Speziali, Mohamed Abuhaleeqa
Publikováno v:
Blood. 128:663-663
Background: Allogeneic hematopoietic cell transplantation (HCT) is an important treatment for adults with acute lymphoblastic leukemia (ALL). The combination of cyclophosphamide with total body irradiation (TBI) at doses of 1200 to 1500 cGy (Cy/TBI12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a43148a429f22bc21a1d64425bd84524
https://doi.org/10.1182/blood.v128.22.663.663
https://doi.org/10.1182/blood.v128.22.663.663